Cyclacel Pharmaceuticals, Inc. announced it raised $7 Million in an initial filing from an offering of $7 Million
Cyclacel Pharmaceuticals, Inc. announced it raised $7 Million in an initial filing from an offering of $7 Million
01/04/21, 4:15 PM
Location
berkeley heightsMoney raised
$7 million
Industry
biopharma
therapeutics
pharmaceutical
biotechnology
Company Info
Location
200 connell drive, suite 1500
berkeley heights, new jersey, united states
Additional Info
Cyclacel Pharmaceuticals, Inc. is a biopharmaceutical company developing innovative cancer medicines based on cell cycle, transcriptional regulation, epigenetics, and mitosis biology. The Company's strategy is to build a diversified biopharmaceutical business based on a pipeline of novel drug candidates addressing oncology and hematology indications.